These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7462687)

  • 21. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.
    Sande MA; Courtney KB
    J Lab Clin Med; 1976 Jul; 88(1):118-24. PubMed ID: 1047088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A general survey of antibiotic treatment of staphylococcal septicaemia and endocarditis.
    Watanakunakorn C
    Scand J Infect Dis Suppl; 1983; 41():151-7. PubMed ID: 6589752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rifampin in the treatment of serious staphylococcal infections.
    Swanberg L; Tuazon CU
    Am J Med Sci; 1984; 287(3):49-54. PubMed ID: 6563847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of resistance to cephalothin and gentamicin during combination therapy for methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
    Chambers HF; Miller MH
    J Infect Dis; 1987 Mar; 155(3):581-5. PubMed ID: 3643249
    [No Abstract]   [Full Text] [Related]  

  • 25. Bactericidal action of nafcillin, vancomycin, and three cephalosporins against nafcillin-susceptible and nafcillin-resistant coagulase-negative staphylococci.
    Mordenti JJ; Davis RH; Lammel CJ; Brooks GF
    Diagn Microbiol Infect Dis; 1986 May; 5(1):1-8. PubMed ID: 3635453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin-resistant mutants.
    Miller MH; Wexler MA; Steigbigel NH
    Antimicrob Agents Chemother; 1978 Sep; 14(3):336-43. PubMed ID: 251069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibility and selection of resistance among Staphylococcus epidermidis isolates recovered from patients with infections of indwelling foreign devices.
    Archer GL
    Antimicrob Agents Chemother; 1978 Sep; 14(3):353-9. PubMed ID: 708013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy.
    Karchmer AW; Archer GL; Dismukes WE
    Ann Intern Med; 1983 Apr; 98(4):447-55. PubMed ID: 6838067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staphylococcal endocarditis. Laboratory and clinical basis for antibiotic therapy.
    Karchmer AW
    Am J Med; 1985 Jun; 78(6B):116-27. PubMed ID: 3893113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative activity of CGP 31608, nafcillin, cefamandole, imipenem, and vancomycin against methicillin-susceptible and methicillin-resistant staphylococci.
    Sachdeva M; Hackbarth C; Stella FB; Chambers HF
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1549-52. PubMed ID: 3481245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus.
    Sullam PM; Täuber MG; Hackbarth CJ; Chambers HF; Scott KG; Sande MA
    Antimicrob Agents Chemother; 1985 May; 27(5):685-7. PubMed ID: 3860185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of teicoplanin in localized experimental infections in rats.
    Arioli V; Berti M; Candiani G
    J Hosp Infect; 1986 Mar; 7 Suppl A():91-9. PubMed ID: 2871103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center.
    Levine DP; Cushing RD; Jui J; Brown WJ
    Ann Intern Med; 1982 Sep; 97(3):330-8. PubMed ID: 7114630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of fosfomycin and vancomycin therapy for experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
    Rodríguez A; Vicente MV; Olay T
    Eur J Clin Microbiol; 1985 Dec; 4(6):603-5. PubMed ID: 3853984
    [No Abstract]   [Full Text] [Related]  

  • 35. Staphylococcus epidermidis endocarditis: a community-acquired methicillin-resistant isolate.
    Lockman DS; Chew WH; Rissing JP
    South Med J; 1983 Sep; 76(9):1203-4. PubMed ID: 6612410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gentamicin- and methicillin-resistant, clinical isolates of Staphylococcus aureus: comparative in vitro and in vivo efficacy of alternative antimicrobial drugs.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1984; 30(2):102-12. PubMed ID: 6559664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of ampicillin plus a beta-lactamase inhibitor (CP-45,899) in experimental endocarditis due to Staphylococcus aureus.
    Washburn RG; Durack DT
    J Infect Dis; 1981 Sep; 144(3):237-43. PubMed ID: 6268715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic-resistant Staphylococcus epidermidis in patients undergoing cardiac surgery.
    Archer GL; Tenenbaum MJ
    Antimicrob Agents Chemother; 1980 Feb; 17(2):269-72. PubMed ID: 6901475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
    Chambers HF; Sachdeva M; Kennedy S
    J Infect Dis; 1990 Sep; 162(3):705-10. PubMed ID: 2387996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rifampin therapy of Staphylococcus epidermidis. Use in infections from indwelling artificial devices.
    Archer GL; Tenenbaum MJ; Haywood HB
    JAMA; 1978 Aug; 240(8):751-3. PubMed ID: 671704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.